UK swine flu vaccine approved

The European Medicines Agency (EMEA) has approved the use of the GSK vaccine Pandemrix, bringing the swine flu vaccination programme a step closer.

All that remains now is for the European Commission to grant European Union-wide marketing authorisations for the vaccine.

The UK has ordered 60 million doses of Pandemrix as well as supplies of a second vaccine produced by Baxter. However, the Baxter vaccine, Celvapan, has still to receive approval from the EMEA.

The EMEA is currently recommending a two-dose vaccination schedule, at an interval of three weeks, for adults, including pregnant women, and children from six months of age.

But the Committee acknowledged that there are preliminary data suggesting that one dose may be sufficient in adults.

The Agency is expecting further data from ongoing clinical studies over the coming months and these recommendations may be updated.

A DoH spokesman said: ‘We are pleased that the European regulator has recommended that the GSK vaccine should be granted a licence by the European Commission.

‘This is a positive step towards getting full licences for vaccine to protect the public.

‘The European Commission must now consider the recommendations and we hope for their decision as quickly as possible.'

GP Online recommends

Swine Flu resource centre

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Social distancing should be cut to 1m in practices, says new IPC guidance

Social distancing should be cut to 1m in practices, says new IPC guidance

Practices can reduce social distancing from 2m to 1m providing the continued use...

Working as a full-time GP in clinical practice is becoming unsafe, RCGP chair warns

Working as a full-time GP in clinical practice is becoming unsafe, RCGP chair warns

The government needs to understand that general practice is a 'safety critical occupation'...

Face-to-face care debate 'too polarised', says NHS England's top GP

Face-to-face care debate 'too polarised', says NHS England's top GP

The face-to-face care debate has become 'too polarised', NHS England's top GP has...

GPs can apply learning from COVID-19 pandemic to fight climate emergency

GPs can apply learning from COVID-19 pandemic to fight climate emergency

GPs can apply learning from the COVID-19 response to help fight the climate emergency...

GP who lost her job to long COVID urges doctors not to underestimate the condition

GP who lost her job to long COVID urges doctors not to underestimate the condition

A GP with long COVID has urged other doctors to listen to patients who have the illness...

GPs must demand strong voice in COVID-19 public inquiry

GPs must demand strong voice in COVID-19 public inquiry

General practice must ensure its voice is heard as national inquiries into the initial...